| Description |
1 online resource (659 pages) |
| Series |
Fundamental and Clinical Cardiology ; v. 39 |
|
Fundamental and clinical cardiology.
|
| Contents |
Series Introduction; Preface to the Third Edition; Preface to the Second Edition; Preface to the First Edition; Contents; Contributors; History of Heparin-Induced Thrombocytopenia; Differential Diagnosis of Acute Thrombocytopenia; Clinical Picture of Heparin-Induced Thrombocytopenia; Frequency of Heparin-Induced Thrombocytopenia; Nonimmune Heparin-Platelet Interactions: Implications for the Pathogenesis of Heparin-Induced Thrombocytopenia; Heparin-Dependent Antigens in Heparin-Induced Thrombocytopenia; Molecular Immunopathogenesis of Heparin-Induced Thrombocytopenia |
|
Role of Sulfated Polysaccharides in the Pathogenesis of Heparin-Induced ThrombocytopeniaThe Platelet Fc Receptor in Heparin-Induced Thrombocytopenia; Immune Vascular Injury in Heparin-Induced Thrombocytopenia; Laboratory Testing for Heparin-Induced Thrombocytopenia; Pseudo-Heparin-Induced Thrombocytopenia; Treatment of Heparin-Induced Thrombocytopenia: An Overview; Danaparoid for the Treatment of Heparin-Induced Thrombocytopenia; Lepirudin for the Treatment of Heparin-Induced Thrombocytopenia; Argatroban Therapy in Heparin-Induced Thrombocytopenia |
|
Bivalirudin for the Treatment of Heparin-Induced ThrombocytopeniaHemodialysis in Heparin-Induced Thrombocytopenia; Management of Cardiopulmonary Bypass Anticoagulation in Patients with Heparin-Induced Thrombocytopenia; Heparin-Induced Thrombocytopenia in Children; Legal Aspects of Heparin-Induced Thrombocytopenia: U.S. Perspectives; Legal Aspects of Heparin-Induced Thrombocytopenia: European Perspectives; Appendixes; APPENDIX 1. TEN CLINICAL ''RULES'' FOR DIAGNOSING HIT; APPENDIX 2. ESTIMATING THE PRETEST PROBABILITY OF HIT: THE FOUR T'S; APPENDIX 3. PLATELET COUNT MONITORING FOR HIT |
|
APPENDIX 4. TREATMENT RECOMMENDATIONS*APPENDIX 5. DANAPAROID DOSING SCHEDULES IN HIT PATIENTS; APPENDIX 6. DOSING SCHEDULES FOR LEPIRUDIN TREATMENT OF PATIENTS WITH HIT; APPENDIX 7. DOSING SCHEDULE FOR LEPIRUDIN IN PATIENTS WITH HIT AND RENAL IMPAIRMENT; APPENDIX 8. DOSING SCHEDULES FOR ARGATROBAN TREATMENT OF PATIENTS WITH HIT (APPROVED INDICATIONS); APPENDIX 9. TIMELINES OF AN EPISODE OF HIT; Index |
| Summary |
Taking stock of advances in clinical recognition, laboratory testing, and pharmacologic therapy as well as basic aspects of pathogenesis, the Third Edition of Heparin-Induced Thrombocytopenia reinforces its standing as the leading guide to accurate diagnosis and effective management of this complex condition. Featuring added chapters on bivalirudin and pediatric heparin-induced thrombocytopenia (HIT), this reference also updates all 20 chapters of the previous edition to regard anew such topics as management of HIT using direct thrombin inhibitors and the special problems of renal failure and |
| Notes |
Print version record |
| Form |
Electronic book
|
| Author |
Greinacher, Andreas
|
| ISBN |
9780203027363 |
|
0203027361 |
|
